Trends in Formulary Coverage of Nonprotected Class Drugs Granted FDA Accelerated Approval. [PDF]
Jazowski SA, Dusetzina SB.
europepmc +1 more source
Deferiprone therapy improves the oxidative status of LDL in patients with β-thalassaemia/HbE. [PDF]
Tran NT +6 more
europepmc +1 more source
Iron Dysregulation in Neurodegeneration with Brain Iron Accumulation (NBIA): Links between Mutations Occurring in BPAN, PKAN, MPAN and PLAN Types and Iron Metabolism. [PDF]
Wiśniewska K +6 more
europepmc +1 more source
Reduction of oxidative stress in total knee arthroplasty using tourniquet with a novel pharmaceutical combination. [PDF]
Tatani I +11 more
europepmc +1 more source
Beta-Thalassemia Major With Iron Overload Cardiomyopathy and Refractory Cardiogenic Shock Requiring Mechanical Circulatory Support. [PDF]
Lim FY +8 more
europepmc +1 more source
Iron Stress Reprograms Enterocyte Metabolism. [PDF]
Navazesh SE, Ji P.
europepmc +1 more source
Reduced number of endothelial progenitor cells in adult patients with beta thalassemia major. [PDF]
Goldberg I +9 more
europepmc +1 more source
Corrigendum: Infratentorial superficial siderosis: report of six cases and review of the literature
Lixia Deng +11 more
doaj +1 more source
Corrigendum to "Mitochondrial ferritin upregulation by deferiprone reduced neuronal ferroptosis and improved neurological deficits via NDRG1/YAP pathway in a neonatal rat model of germinal matrix hemorrhage". [PDF]
europepmc +1 more source
Efficacy and safety of deferiprone for thalassemia: a systematic review and meta-analysis of randomized controlled trials. [PDF]
Wilar G, Suhandi C, Kawahata I.
europepmc +1 more source

